studied in detail. We found a divergent pattern of killing, that is, certain peptides and proteins exhibited selective activity against specific pathogens, while others displayed a broader antimicrobial activity. ␣ -Defensins, LL-37 and calprotectin were active against all species, while lactotransferrin exclusively inhibited growth of S. aureus . Conversely, azurocidin was active against all species except S. aureus . Our observations may shed light on bacterial resistance to AMPs and on the elimination of specific bacterial communities on mucosal surfaces.
Introduction
Polymorphonuclear leukocytes (PMNs or neutrophils) are the first immune cells recruited to a site of infection, where they maintain host defense until adaptive immune cells are activated. Neutrophils contain a number of antimicrobial peptides and proteins (AMPs) that work in concert with the respiratory burst to achieve microbial killing [1] . The importance of neutrophils in host defense against pathogens is well established, in both mouse models and neutropenic patients. In mice, depletion of neutrophils leads to a marked reduction in clearance of bacteria from the lungs. Conversely, host defense was restored when these mice were augmented with neutrophils [2] . Similarly, in humans it has been shown that neutropenia confers an increased risk of infections in general, but in particular in the upper respiratory tract (sinusitis, otitis media) and in the lung [3, 4] . Furthermore, patients suffering from severe congenital neutropenia (Kostmann syndrome) are susceptible to bacterial infections of the respiratory system, ears and skin [5] . Despite treatments that restore neutrophil levels, these patients still suffer from recurrent infections, which has been suggested to be dependent on reduced levels of AMPs [6] . A selective lack of neutrophil-derived AMPs has also been demonstrated for the rare diseases Chediak-Higashi syndrome and specific granule deficiency, which are characterized by frequent and severe bacterial infections [7] . Combined, these observations suggest that both mice and humans are dependent on PMNs for clearance of infections and that their AMPs contribute to the defense against pathogenic microbes.
Neutrophil-derived AMPs can be divided into 3 general (and sometimes overlapping) groups based on their mechanism of antimicrobial action: cationic amphipathic peptides and proteins, chelating proteins and AMPs with enzymatic activity. The antimicrobial function of these peptides and proteins is generally well established, as well as their mechanism of bacterial killing [8] [9] [10] [11] [12] [13] . However, previous studies of neutrophil-derived AMPs have mainly focused on the antimicrobial properties of a few selected AMPs or have utilized strict proteomic approaches without addressing antimicrobial activity. Furthermore, previous investigations with the aim of identifying novel AMPs have often been based on read-outs of antimicrobial activity against 'laboratory' bacterial strains, such as Bacillus megaterium (Bm11) or other modified bacterial strains. These strains are sensitive tools for detection of antimicrobial activity, but not always of clinical relevance. In conclusion, detailed information on which of the numerous neutrophil-derived antimicrobial peptides and proteins that is most important in the killing of human pathogens remains elusive. Therefore, we performed a screening experiment with the aim of elucidating the role of specific AMPs in the killing of 4 primary or opportunistic human pathogens: Staphylococcus aureus, Haemophilus influenzae, Moraxella catarrhalis and Candida albicans .
In this study, we identified 3 AMPs with a cationic character [ ␣ -defensins (HNP1-3), azurocidin and hCAP18/LL-37], 2 metal-chelating AMPs (calprotectin and lactotransferrin, LTF), 2 antimicrobial enzymes (lysozyme and cathepsin G), as well as several histones (H1, H2B, H3 and H4), implicated in the antimicrobial activity against the tested pathogens. By depletion experiments with specific antibodies we could demonstrate that: (1) HNP1-3, calprotectin and LL-37 are important for the killing of all 4 pathogens analyzed, (2) LTF contributes to the killing of S. aureus but not to the killing of any of the other pathogens investigated and (3) azurocidin is important for the killing of H. influenzae, M. catarrhalis and C. albicans, but is not active against S. aureus .
This knowledge may be useful in the search for underlying mechanisms involved in clinical conditions of susceptibility to bacterial or fungal infections.
Materials and Methods

Isolation of PMNs
PMNs were isolated from buffy coats of healthy donors as previously described [14] . Briefly, buffy coats ( ! 5 h from venipuncture) provided by Karolinska Hospital Blood Bank, Stockholm, Sweden were subjected to dextran sedimentation and hypotonic lysing of erythrocytes. Thereafter, the sample was subjected to a density gradient centrifugation on Lymphoprep (Axis-Shield PoC AS, Oslo, Norway). The isolated PMNs were resuspended in PBS (without Ca 2+ and Mg
2+
) to a concentration of 10 ! 10 6 cells/ml and assayed for purity and viability using Hemacolor (J.T. Baker, Utrecht, The Netherlands) and Trypan blue (Sigma-Aldrich, St. Louis, Mo., USA).
Extraction of Neutrophil-Derived Polypeptides
PMNs were extracted in 60% acetonitrile (AcN) containing 1% trifluoroacetic acid (TFA) in 4 ° C, subjected to centrifugation at 10,000 g , and the resulting supernatant of the PMN extract was lyophilized.
Degranulation of PMNs
PMNs (1 ! 10 7 cells) were stimulated with 100 n M of formylmethionyl-leucyl-phenylalanine (fMLP; Sigma-Aldrich) in PBS (without Ca 2+ and Mg 2+ ) for 5 min followed by stimulation with 10 M of cytochalasin B (Sigma-Aldrich) for 5 min. The resulting PMN supernatant was collected and lyophilized.
Enrichment of Neutrophil-Derived Polypeptides
Both the PMN supernatant and the PMN extract were reconstituted in 0.1% TFA and enriched for polypeptides on OASIS 3cc HLB columns (Waters, Milford, Mass., USA), which had previously been activated with AcN and equilibrated in 0.1% TFA. Polypeptides were eluted with 80% AcN in 0.1% TFA followed by lyophilization. The lyophilized materials were reconstituted in 0.1% TFA and the protein concentrations were determined using the Bradford protein assay [15] . The flow-through from the OASIS column did not contain any components with antimicrobial activity (data not shown).
Purification of Neutrophil-Derived Polypeptides of PMN Extract
The enriched PMN extract was separated by reversed-phase high-performance liquid chromatography (HPLC) utilizing a Vydac C8 column (4.6 mm ! 250 mm; Grace, Columbia, Md., USA) over a gradient of 0-80% AcN in 0.1% TFA using ÄKTA purifier HPLC (GE Healthcare, Buckinghamshire, UK). The absorbance was monitored at 215 nm. Fractions of 1 ml were collected and lyophilized. The lyophilized fractions were reconstituted in 100 l water. 
Bacterial and Fungal Species
Inhibition Zone Assay
The chromatographic fractions were assayed using a modified version of the radial diffusion assay [16] against the isolates of S. aureus strain Newman, H. influenzae , M. catarrhalis and the fungus C. albicans . Briefly, microbes were grown to an optical density of 0.6 in different growth media: S. aureus , Luria-Bertani broth; C. albicans , yeast and mold media; M. catarrhalis and H. influenzae , brain and heart infusion media with 2% Fildes supplement [containing pepsin-digested horse blood, hemin (X factor) and NAD (V factor)] (Oxoid, Cambridge, UK). Thereafter the microbes were diluted to 6 ! 10 4 CFU/ml in 10% growth media containing 1% agarose (A-6013; Sigma-Aldrich) with the exception of H. influenzae , which was assayed in 10% brain and heart infusion media supplemented with 1% Fildes, spread out into a 90-mm Petri dish (Sarstedt AG & Co., Nümbrecht, Germany) and set to harden (final depth of agarose layer: 1 mm). Holes of 3 mm in diameter were punched into the solidified agarose layer and 3 l of each chromatographic fraction was added to each hole. The plates were incubated at 35 ° C overnight.
Gel Electrophoresis
Chromatographic fractions were dissolved in lithium dodecyl sulfate sample buffer (Invitrogen, Carlsbad, Calif., USA), containing 50 m M dithiothreitol (Sigma-Aldrich). The samples were incubated at 70 ° C for 10 min and separated by SDS-PAGE, on 4-12% NuPage Bis-Tris gels (Invitrogen) at 200 V for 35 min. Gels were stained with 0.1% Coomassie Brilliant Blue in 90% water, 8% methanol and 2% acetic acid (v/v/v) for 1 h and destained overnight in 90% water, 8% methanol and 2% acetic acid (v/v/v).
Dot Blot Analysis
For dot blot analysis 1/100 of each chromatographic fraction was spotted onto a Hybond Super C nitrocellulose membrane (Amersham Biosciences, Buckinghamshire, UK). The membrane was treated with 5% fat-free milk in PBS for 1 h at room temperature (RT). After washing with 0.25% Tween in PBS the membrane was incubated with 0.6 g/ml of primary antibody in 5% fat-free milk in PBS, 0.25% Tween 20 (Sigma-Aldrich) at RT for 1 h. After an additional PBS washing step a secondary horseradish peroxidase-conjugated antibody was added and the membrane was incubated for 1 h. Proteins and peptides were visualized on chemiluminescence film using the ECL plus Western blot detection system (GE Healthcare).
Antibodies: monoclonal antibody specific for LL-37 [17] , S100A8 (goat polyclonal IgG, sc-8112; Santa Cruz, Santa Cruz, Calif., USA), HNP (goat polyclonal IgG, sc-22916; Santa Cruz), azurocidin (rabbit polyclonal IgG, sc-33129; Santa Cruz), lactotransferrin (mouse monoclonal, sc-52048; Santa Cruz), Lysozyme (rabbit polyclonal, A-0099; Dako, Stockholm, Sweden), Cathepsin G (rabbit polyclonal, ASHCG-AS; Molecular Innovations, Novi, Mich., USA).
Western Blot Analysis
For Western blot analysis, 1/25 of the chromatographic fractions were dissolved in lithium dodecyl sulfate sample buffer and separated as described above in the Gel Electrophoresis section. After the electrophoretic separation, proteins in the gels were blotted onto a polyvinylidene fluoride membrane (Invitrogen) at 30 V for 1 h. Blocking and detection of polypeptides on the polyvinylidene fluoride membrane was performed as described in the Dot Blot Analysis section.
Trypsin Digestion and Peptide Mass Fingerprinting
Gel bands were manually excised and proteins were in-gel digested with trypsin using the MassPREP robotic protein handling system (Waters). The gel pieces were destained twice with 100 l 50 m M ammonium bicarbonate (Ambic) in 50% (v/v) AcN at 40 ° C for 10 min. Subsequently the polypeptides were reduced with 10 m M dithiothreitol in 100 m M Ambic for 30 min, alkylated with 55 m M iodoacetamide in 100 m M Ambic for 20 min, and dehydrated in AcN. To the sample solutions, 300 ng trypsin (Promega, Madison, Wisc., USA) in 50 m M Ambic was added and incubated for 5 h at 40 ° C. Peptides were eluted from the gel pieces by using 30 l 1% formic acid in 2% AcN, followed by extraction in 3 ! 15 l 50% AcN. Tryptic peptides were mixed 1: 1 (v:v) with saturated ␣ -cyano-4-hydroxycinnamic acid (Bruker Daltonics, Billerica, Mass., USA), previously diluted 1: 3 in 70% AcN. The molecular weights of the fragments were determined using the Voyager-DE TM PRO matrix-assisted laser desorption/ionization mass spectrometer (MALDI-MS; Applied Biosystems, Foster City, Calif., USA). The polypeptides were identified by database searches utilizing the MASCOT search engine with the UniProtKB/SwissProt Release 57.3 database.
Depletion of the Activity of Individual AMPs in the PMN Extract and Active Chromatographic Fractions
After identifying proteins in the antimicrobially active chromatographic fractions using peptide mass fingerprinting (PMF), several fractions were grouped into clusters (I-VII) and pooled accordingly. To verify the contribution of specific AMPs to the total antimicrobial activity in a cluster, AMPs identified in the clusters were subjected to depletion of the antimicrobial activity using specific polyclonal or monoclonal antibodies directed against the individual AMPs identified by PMF. The pooled fractions were lyophilized and reconstituted in either specific antibody (final concentration 3 mg/ml), sterile water or an unspecific control antibody. The control antibodies were chosen to match the specific anti-AMP antibodies: mouse monoclonal an-ti-rabbit IgG (Sigma R1008), rabbit polyclonal anti-tubulin (Sigma SAB3500023) and goat polyclonal anti-␤ -actin (Abcam; ab8229). These antibodies did not reduce any antimicrobial activity by themselves at the concentration of 3 mg/ml ( fig. 4 , 5 a; data not shown). The mixtures were incubated at RT for 1 h. The reduction in activity of fractions blocked with the specific or control antibody was assayed in the inhibition zone assay as described above. For depletion experiments, the PMN extract (25 g/ l) was reconstituted in either PBS, control antibody (final concentration 3 mg/ml) or an AMP-specific antibody (final concentration 3 mg/ml) at RT for 1 h, and the antimicrobial activity was assayed in the inhibition zone assay.
Minimum Inhibitory Concentration HNP1-3 (AbD Serotech, Oxford, UK), recombinant human azurocidin (provided by Prof. Lennart Lindbom, Karolinska Institutet), calprotectin heterodimer (S100A8/A9; provided by Dr. Walter J. Chazin, Vanderbilt University, USA), LTF and human lysozyme (L-6394; Sigma-Aldrich) and LL-37 (Innovagen, Lund, Sweden) were analyzed in the inhibition zone assay for determination of the minimum inhibitory concentration (MIC) [18] . Histone sulfate from calf thymus containing H1, H2A, H2B, H3 and H4 (Fluka AG, Buchs, Switzerland) was utilized for MIC determination of histones. These bovine histones are highly homologous to human histones (H1: 95.4% sequence identity, H2A: 100%, H2B: 99.2%, H3: 97% and H4: 100% identity). Briefly, 2-fold dilutions of each AMP in sterile water were analyzed in the inhibition zone assay and the diameters of the zones were corrected by subtraction of the hole diameter (3 mm). Linearity was observed when plotting the logarithm of the peptide concentration as a function of the corrected zone diameter. Using linear regression (least squares algorithm), the MIC was determined as the intercept of the linear regression with the x-axis.
Results
Extraction and Purification of Neutrophil-Derived AMPs
To investigate the antimicrobial properties of neutrophil-derived peptides and proteins, PMNs pooled from 4 healthy blood donors were either extracted with 1% TFA in 60% AcN (PMN extract) or degranulated using fMLP and cytochalasin B, and the supernatant was collected (PMN supernatant). The PMN extract and the PMN supernatant were then enriched for polypeptides and their antimicrobial activities were compared. Both exhibited antimicrobial activity against 4 common human pathogens (S. aureus, H. influenzae, M. catarrhalis and C. albicans) when tested in an inhibition zone assay. The most sensitive bacterium was M. catarrhalis (zone diameter of 11 mm for the PMN extract and 9.5 mm for the PMN supernatant), whereas the most resistant pathogen was H. influenzae (zone diameter of 7 mm for the PMN extract and 6.5 mm for the PMN supernatant) fig. 1 a) . The AMP compositions in the PMN extract and supernatant were investigated utilizing Western blot analyses with antibodies directed against peptides of primary (HNP1-3 [8] ) and secondary (LL-37 [19] ) granules. The PMN extract and the PMN supernatant contained similar amounts of these AMPs ( fig. 1 b) and since the antimicrobial activities did not differ considerably between the PMN extract and supernatant ( fig. 1 a) , we chose to use PMN extracts for further experiments. A further reason for using a whole-cell extract was that we wanted to include all cellular compartments of the neutrophil, including nuclear, cytoplasmic as well as granular peptides and proteins. We reasoned that this approach may be important since neutrophils are shortlived cells (approximately 24 h) and have dual antibacterial functions, utilizing phagolysosomal as well as neutrophil extracellular trap (NET)-mediated bacterial killing. Thus, we aimed at investigating AMPs being involved in both of these processes.
Identification of Antimicrobial Polypeptides
In order to identify the individual components that contributed to the observed antimicrobial effect of the PMN extract, further isolation was performed by reversed-phase HPLC. The antimicrobial activity of the chromatographic fractions plotted in figure 2 a-e segregated into a number of distinct clusters (I-VII). For further identification of AMPs, fractions from the different clusters were separated on SDS-PAGE. Excised protein bands were in-gel digested and analyzed using PMF. 
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Two clusters exhibited activity against all 4 pathogens (cluster I and cluster IV, fig. 2 b-e). The first (cluster I, fraction 19-21) eluted at 25-30% AcN and represents peptides/proteins with moderate hydrophobicity. SDS-PAGE revealed a single band of 4 kDa ( fig. 3 ; table 1 ), which was shown to contain HNP1-3 by PMF and dot blot analysis (data not shown). The other cluster with activity against all test strains eluted at 38% AcN (cluster IV, fraction 74-77) and the fraction with the highest activity of this cluster (fraction 76), contained S100A8 (6.5 kDa), lysozyme C (14 kDa), cofilin-1 (18 kDa), azurocidin (25 kDa) and LTF (80 kDa) by PMF ( fig. 3 ;  table 1 ).
Three clusters were exclusively active against C. albicans and M. catarrhalis . They eluted at 30-35% AcN (cluster II, fractions 49-61), 35-38% AcN (cluster III, fractions 63-68) and 40-45% AcN (cluster V, fractions 82-106 ( fig. 2 d, e) . Fractions 54-57 of cluster II contained 3 major polypeptides of approximately 7, 25 and 30 kDa. These were identified with PMF to be platelet factor 4 (9 kDa), high-mobility group protein B1 (26 kDa) and histone H1 (35 kDa). Fractions 60 and 61 of cluster II contained both cathepsin G (28 kDa) and histone H1 (30 kDa) as determined by PMF ( fig. 3 ; table 1 ).
In fraction 67 of cluster III, cathepsin G (30 kDa) could be identified, utilizing PMF ( fig. 3 ; table 1 ) and dot blot analysis (data not shown).
Fractions 87 and 88 of cluster V (82-106) contained S100A8 (11 kDa), histone H4/H2B (12/15 kDa), lysozyme C (14 kDa), tropomyosin ␣ -4 (29 kDa), vimentin (55 kDa) and LTF (80 kDa), as shown with PMF ( fig. 3 ; table 1 ).
The PMF data were further verified with immunoblotting using antibodies directed against HNP1-3, calprotectin, azurocidin, cathepsin G, lysozyme C and LTF (data not shown). In addition, hCAP18 was identified in fractions 98-103 of cluster V with MALDI-MS and PMF. Furthermore, the mature peptide LL-37 could be detected in these fractions by Western blot analysis, utilizing a monoclonal antibody directed against LL-37 (data not shown).
Several hydrophobic components that eluted around 50% AcN (cluster VI, 117-120) were active against S. aureus, H. influenzae and moderately active against M. catarrhalis . Fraction 118 in cluster VI contained the calprotectin heterodimer S100A8/A9 (10/13 kDa), hemoglobin subunit ␤ (14 kDa) and histone H3 (15 kDa), as determined by PMF ( fig. 3 ; table 1 ). The most hydrophobic components (cluster VII, fractions 128-131) exhibited exclusive activity against H. influenzae and fractions 129- I dentification of polypeptides detected in fractions was performed using MALDI-MS. Gel bands were excised from the SDS-PAGE ( fig. 3 ) in-gel digested with trypsin and identified using PMF.
131 were shown to contain calprotectin (10/13 kDa), as shown by PMF ( fig. 3 ; table 1 ).
Depletion of Antimicrobial Activity from Specific AMPs in Pooled Fractions
Since most fractions contained several AMPs, it was necessary to determine the contribution of individual AMPs to the observed antimicrobial activity. Thus, depletion experiments with specific antibodies directed against individual antimicrobial polypeptides in clusters I-VII were carried through ( fig. 4 ) .
First, the specific antibodies were co-incubated with their respective synthetic peptide. This resulted in nearly full blocking of antimicrobial activity, demonstrating that the antibodies exhibited a blocking capacity (data not shown). When pooled fractions from cluster I were co-incubated with antibody against HNP1-3, a significant reduction in antimicrobial effect could be observed for all strains. In contrast, no reduction in antimicrobial activity was detected upon incubation of cluster II with antibody against cathepsin G. Similarly, when fractions from cluster III were incubated with antibody directed against LTF, no significant reduction in antimicrobial activity against M. catarrhalis or C. albicans could be recorded.
When cluster IV was blocked with antibody against azurocidin, a significant reduction in antimicrobial activity against H. influenzae , M. catarrhalis and C. albicans was observed. Notably, when the same fractions were incubated with LTF antibody, the antimicrobial effect against S. aureus was attenuated, indicating speciesspecific effects of azurocidin and LTF.
For cluster V the antimicrobial activity directed against H. influenzae , M. catarrhalis and C. albicans was reduced after incubation with LL-37 antibody, whereas no reduction in activity was observed after application of antibody against S100A8. A significant reduction in antimicrobial activity occurred when cluster VI was incubated with S100A8 antibody for all species, except for C. albicans . Finally, fractions in cluster VII were only active against H. influenzae and the antimicrobial effect was significantly reduced by co-incubation with the S100A8 antibody. Combined, these experiments indicate that HNP1-3 and S100A8/A9 contribute to the antimicrobial activity against all species tested. The antimicrobial activity against H. influenzae , M. catarrhalis and C. albicans detected in cluster IV is exerted by azurocidin. However, azurocidin does not appear to play a major role in the detected activity against S. aureus . In contrast, LTF contributes to the observed antimicrobial effect directed against S. aureus in cluster IV , but not against the other pathogens investigated.
Depletion of Antimicrobial Activity in PMN Extract
Since most of the AMPs detected were found in several fractions with antimicrobial activity, we sought to evaluate the contribution of each AMP by depletion experiments of PMN extract utilizing antibodies against HNP1-3, azurocidin, lysozyme, cathepsin G, S100A8, LL-37 and LTF ( fig. 5 a) . After incubation of the PMN extract with antibodies against HNP1-3, S100A8 or LTF, a significant reduction in antimicrobial activity against S. aureus was observed. In contrast, antibodies against azurocidin, lysozyme, cathepsin G or LL-37 did not significantly reduce the anti-staphylococcal activity of the PMN extract. For H. influenzae, depletion of the PMNextract with antibodies against HNP1-3, azurocidin or S100A8 resulted in a significant reduction in antimicrobial activity. A marked but not significant reduction was also observed in the PMN extract depleted with LL-37 antibody. No reduction in antimicrobial activity was detected utilizing antibodies directed against lysozyme, cathepsin G or LTF. The highest activity of the PMN extract was against M. catarrhalis and depletion experiments revealed that HNP1-3, azurocidin, S100A8 and LL-37 likely contributed to this activity.
In addition, the PMN extract had a potent anti-candida activity and similar depletion experiments indicated a role for HNP1-3 and S100A8 in the killing or inhibition of C. albicans ( fig. 5 a) .
PMN Extract Supplemented with Zinc and Iron
Since we detected calprotectin and LTF in our screen, we wanted to determine the contribution of these and other metal-chelating AMPs to the activity of the PMN extract. Zinc has been shown to inhibit the bacteriostatic effects of calprotectin, present in large amounts in neutrophils. The exact mechanism behind this effect is not fully elucidated, but both zinc chelation [20] and other mechanisms have been proposed [21] . Further, ferrous iron abrogates the bacteriostatic effect of LTF [20, 22] . We exploited these mechanisms to determine if any of the activity in the extract could be ascribed to calprotectin, LTF or other antimicrobial proteins that inhibit bacterial growth by a similar mechanism. PMN extract was dissolved in either water or ZnSO 4 , FeSO 4 and MgCl 2 solutions and the antimicrobial activity was measured. ZnSO 4 reduced the antimicrobial activity with 35% for S. aureus, with 23% against H. influenzae, with 28% against M. catarrhalis and with 18% against C. albicans ( fig. 5 b) . FeSO 4 resulted in a similar reduction in activity but with a slightly less pronounced effect ( fig. 5 b) . MgCl 2 did not significantly alter the diameter of the inhibition zones for any of the species. Importantly, addition of ions did not alter the effect of a nonchelating AMP (LL-37), suggesting that the ions inactivated metal-chelating AMPs rather than inhibited the growth of the microorganism ( fig. 5 b) .
MIC of Individual AMPs
To further establish a role in host defense for the identified AMPs and to corroborate the depletion experiments, MIC values of all 4 pathogens were determined by serial dilutions of each peptide in the inhibition zone assay ( table 2 ) . LL-37, HNP1-3 and calprotectin were found to inhibit growth of all 4 microorganisms. However, HNP1-3 and LL-37 exhibited slightly enhanced activity against H. influenzae and M. catarrhalis compared to C. albicans and S. aureus when tested in the inhibition zone ( table 2 ) .
The presence of histones in several fractions with antimicrobial activity against C. albicans and M. catarrhalis and previous indications of antimicrobial activity of histones [23] [24] [25] led us to investigate the functional role of histones as antimicrobial proteins. Thus, histone sulfate (containing H1, H2A, H2B, H3 and H4 of bovine origin) was evaluated against the 4 test microbes. Interestingly, this mixture exhibited activity exclusively against M. catarrhalis and C. albicans , which suggests that histones contributed to the observed activity against these microbes in cluster II, III and V ( fig. 2 ; table 2 ) . Combined, the main findings of the antimicrobial activity against the selected microbes that originate from individual AMPs are summarized in figure 6 .
Discussion
Neutrophils contain numerous polypeptides with antimicrobial activity. Many of these have been thoroughly investigated in association with specific microbes. Here we extend previous findings with a novel screening approach with the aim to determine the specific 'set' of AMPs in neutrophils that is important in killing 4 human pathogens. Our hypothesis is that distinct sets of AMPs may have been evolutionarily adapted to interact with specific pathogens. Our current results support this idea and, indeed, we found that each pathogen is killed by several distinct AMPs with different mechanisms of action. A parallel attack using these AMPs exhibits a formidable threat to bacteria and an adaptation making them resistant to this combined assault is unlikely and would lead to a gross cost on bacterial fitness. Thus, the concept of attacking a microbe with multiple AMPs is perfectly exploited by neutrophils.
In the PMN extract we have identified 5 AMPs (HNP1-3, calprotectin, LTF, azurocidin and LL-37), which together appear to be responsible for a significant portion of the detected antimicrobial activity against the selected pathogens. In the depletion studies with specific antibodies and with MIC analyses for the individual AMPs, we encountered both specificity and redundancy in antimicrobial activity. The MIC values were in accordance with the depletion experiments, that is, if the activity of a polypeptide could be depleted, the MIC value for this polypeptide was low (calprotectin vs. S. aureus ). Similarly, failure of depletion correlated with a high MIC value (LTF vs. H. influenzae ). In addition, we identified hCAP18 (the precursor to LL-37) in our screen by using mass spectrometry with PMF. This precursor protein of 17 kDa has no known antimicrobial activity per se. Nevertheless, we did observe a reduction in activity against H. influenzae, M. catarrhalis and C. albicans in the hCAP18-containing fractions, when depleting the activity with a monoclonal antibody against LL-37, which indicated the presence of active LL-37 in these fractions ( fig. 4 ) . Indeed, Western blot analysis of the PMN extract revealed that mature LL-37 was present ( fig. 1 b) . In addition, our MIC experiments suggest that LL-37 is active in vitro against S. aureus , which is in line with published data where MIC values for LL-37 against S. aureus strains varied between 2.9 and 2.5 M [18] . However, the depletion experiments revealed that LL-37 appears to contribute very little to the total activity of the PMN extract against S. aureus ( fig. 4 , 5 a) . That both the holoprotein hCAP18 and LL-37 elute from the HPLC column in the same fraction has been observed before and suggests that they have a similar hydrophobicity index or that proteases cleave off LL-37 during the preparation [26] .
We also identified lysozyme and cathepsin G, which are known antimicrobial polypeptides. However, antibodies directed against these proteins did not reduce the antimicrobial activity of the chromatographic fractions in which they were identified, indicating the presence of unidentified or untested AMPs in these fractions. Since we used a harsh extraction procedure (1% TFA in 60% acetonitrile), the antimicrobial activity of enzymatic AMPs such as cathepsin G may have been disrupted through denaturation. This may explain why fractions containing antimicrobial enzymes did not exhibit antimicrobial activity in the inhibition zone assay. Therefore, this limitation of our screen infers that we cannot rule out a role for cathepsin G, lysozyme or other enzymatic AMPs in neutrophil-derived killing of the 4 selected pathogens. However, purified lysozyme was not very effective in killing any of the tested microbes in our MIC analysis ( table 2 ) , which is consistent with previous findings that clinical isolates are resistant against this AMP as part of their virulence [27] . Importantly, the extraction procedure did not interfere with the activity of cationic and metal-binding AMPs, since identified defensins, hCAP18/LL-37, azurocidin, calprotectin as well as LTF were active in our screen. In addition, we identified histones in several fractions with activity against M. catarrhalis and C. albicans ( fig. 2 , clusters II, III and V; tables 1 , 2 ). The contribution of histones to this activity was supported by our MIC assay on histone sulfate, which exhibited activity predominantly against M. catarrhalis and C. albicans ( table 2 ) . Thus, our results support previous work on histones [25] and are in line with the emerging concept that histones function as true AMPs [23] . In fact, several histones have been found in NETs, where they contribute to bacterial and fungal killing together with other AMPs [28, 29] .
To include both nuclear, cytoplasmic as well as granular neutrophil-derived proteins in our antimicrobial screen, whole neutrophils were lysed and enriched for peptides and proteins. Thus, our extraction procedure yielded neutrophil-derived polypeptides from both membrane-bound and intracellular compartments, including all subsets of neutrophil granules. Indeed, we have found both ␣ -defensins 1-3 and azurocidin from primary granules, LTF, LL-37 and NGAL from the specific granules as well as cofilin 1 and vimentin from gelatinase granules [30] . Further, we identified the cytosolic calprotectin heterodimer (S100A8/A9) as an important AMP in neutrophils. Calprotectin (also called calgranulin) resides in the cytosol and is the most abundant protein in human neutrophils, constituting approximately 45% of the total protein content in these cells [31] . It has been demonstrated that calprotectin plays an important role in growth inhibition of C. albicans by necrotic neutrophils [32] as well as by NETs [28] .
The MIC values that we obtained were in the same range as previously published MIC values for these AMPs versus the respective microbe [18, 20, 21, [33] [34] [35] ever, MIC values of AMPs should be compared with caution since conditions differ significantly between laboratories and there is currently no consensus in this methodology. We investigated several different conditions and chose the method which could be used for all peptides and microbes. Moreover, metal-chelating AMPs such as calprotectin and LTF had to be analyzed in a medium low in divalent cations, in order to avoid saturation of the binding sites for these ions that would block the bacteriostatic mechanism of action. This may have influenced the growth of the organism and thus the resulting MIC values. Another factor that influences the MIC value is the bacterial strain used. Here we have used clinical isolates, which may be relevant for future studies into this area, where biological samples from patients are investigated. Combined, our experiments reveal that neutrophils kill bacteria by using a wide range of AMPs, utilizing different mechanisms of action for killing or growth restriction. This represents an example of redundancy that has often been suggested, but not proven, concerning the role of AMPs in host defense. The fact that several AMPs kill bacteria simultaneously, and by different mechanisms, minimizes the risk of bacterial resistance. On the other hand, AMPs exhibit a specific action to many bacteria. This phenomenon may explain why the composition of the normal flora varies between different body sites. The skin releases psoriasin, an S100 protein inhibiting bacterial growth by chelating Zn 2+ , which readily kill Escherichia coli , but is inactive against S. aureus [36] . Recently, Salzman et al. [37] showed that mice expressing human defensin 5 have an altered composition of the normal flora compared to wild-type mice. Thus, the emerging concept is that AMPs contribute to the shaping of the normal flora at mucosal surfaces. Therefore, it is important to delineate the precise role of each AMP against individual bacterial species.
However, an important limitation with our approach is that we study individual components separately. Thus, we do not discover synergistic activity between the different AMPs, suggesting that we probably underestimate the total effect of AMPs in the neutrophil antimicrobial repertoire.
In addition to exploring the role of AMPs in relation to the normal flora, there are ongoing attempts to induce AMPs as a strategy to treat infections [38] . Our results point out a role for HNP1-3 and calprotectin against all pathogens investigated, while LL-37, LTF and azurocidin exhibited a narrower spectrum. Interestingly, recent data show that LL-37, calprotectin and azurocidin are expressed in bronchial epithelial cells and are induced by IL-17 and IL-22 [39, 40] . These cytokines are released from a newly described T helper cell subset, the T h 17 cells, which have been suggested to be master regulators of mucosal defense. Notably, cytokines released from T h 17 cells also recruit neutrophils to the site of infection. Thus, the final outcome of T h 17 cell activation at the site of infection is a rapid increase in AMP levels, which originate both from epithelial cells and PMNs [41] . Notably, several recent reports describe conditions where deficient T h 17 cell responses are implicated in susceptibility to severe S. aureus and C. albicans infections [42] [43] [44] . We speculate that these conditions may also result in a deficiency of specific AMPs and we believe that our present results on neutrophil-derived AMPs may be useful for future studies on clinical entities involving susceptibility to bacterial and fungal infections.
